bestinclass

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Source Node:
Time Stamp: February 2, 2024 2:30 PM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

  New York, Feb 2, 2024 - (Plato Data)- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang. Avenue Therapeutics Finalizes Phase 3 Study for IV Tramadol with FDA Avenue Therapeutics, a subsidiary of Fortress Bio, has reached a significant milestone in its quest to introduce new therapies for neurologic diseases. The company

Plato Data Intelligence Leverages Vectara to Power its Data-As-A-Service / DaaS Platform

Source Node:
Time Stamp: January 18, 2024 1:36 PM - Modified On: January 18, 2024 - Published By:
Source Cluster:
Republished By Plato

From development to launch, Vectara’s GenAI technology and team help innovators get to market faster. The announced partnership breaks new ground towards deploying a next generation of GenAI tools with Vertical focus. Vectara, the Trusted Generative AI Product Platform, and Plato Data Intelligence, creators of PlatoAi, have entered into a commercial agreement to unlock the power of Vectara via Plato AI’s Generative Intelligence platform. With an emphasis on secure, trustworthy, and transparent GenAI for enterprises, Vectara was the clear choice for developers who want a trusted provider to count on

SCCG Announces Strategic Partnership with AWARE, A Global Leader in KYC Software Solutions

Source Node:
Time Stamp: August 7, 2023 12:39 PM - Modified On: August 7, 2023 - Published By:
Source Cluster:
Republished By Plato

SCCG Management announced a strategic partnership with AWARE, a world leader in biometric verification software solutions. This partnership aims to establish AWARE’s superior biometric software solutions in the global gambling industry, with SCCG leading the charge to distribute these innovative solutions to major operators worldwide. AWARE, a pioneering company listed on the NASDAQ under the ticker symbol "AWRE," has dramatically transformed the landscape of security and authentication with its comprehensive portfolio of innovative biometric solutions. These ground-breaking solutions enable secure biometric enrollment, authentication, and identity verification, facilitating seamless transactions, and